Your browser doesn't support javascript.
loading
Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma.
Ceresoli, G L; Zucali, P A; Mencoboni, M; Botta, M; Grossi, F; Cortinovis, D; Zilembo, N; Ripa, C; Tiseo, M; Favaretto, A G; Soto-Parra, H; De Vincenzo, F; Bruzzone, A; Lorenzi, E; Gianoncelli, L; Ercoli, B; Giordano, L; Santoro, A.
Affiliation
  • Ceresoli GL; Department of Medical Oncology, Cliniche Humanitas Gavazzeni, Bergamo, Italy. giovanni_luca.ceresoli@gavazzeni.it
Br J Cancer ; 109(3): 552-8, 2013 Aug 06.
Article in En | MEDLINE | ID: mdl-23860535
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pleural Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Mesothelioma Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2013 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pleural Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Mesothelioma Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2013 Document type: Article Affiliation country: Country of publication: